WO1990012788A3 - ACETALISCH GESCHÜTZTE ENANTIOMERENREINE α-ARYLALKANCARBONSÄUREN, DEREN HERSTELLUNG UND VERWENDUNG - Google Patents

ACETALISCH GESCHÜTZTE ENANTIOMERENREINE α-ARYLALKANCARBONSÄUREN, DEREN HERSTELLUNG UND VERWENDUNG Download PDF

Info

Publication number
WO1990012788A3
WO1990012788A3 PCT/AT1990/000038 AT9000038W WO9012788A3 WO 1990012788 A3 WO1990012788 A3 WO 1990012788A3 AT 9000038 W AT9000038 W AT 9000038W WO 9012788 A3 WO9012788 A3 WO 9012788A3
Authority
WO
WIPO (PCT)
Prior art keywords
acetalically
enantiomer
pure
protected
production
Prior art date
Application number
PCT/AT1990/000038
Other languages
English (en)
French (fr)
Other versions
WO1990012788A2 (de
Inventor
Christian R Noe
Max Knollmueller
Marion Letschnig
Armin Holzner
Original Assignee
Christian R Noe
Max Knollmueller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian R Noe, Max Knollmueller filed Critical Christian R Noe
Publication of WO1990012788A2 publication Critical patent/WO1990012788A2/de
Publication of WO1990012788A3 publication Critical patent/WO1990012788A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft acetalisch geschützte enantiomerenreine α-Arylalkancarbonsäuren der allgemeinen Formel (I), in welcher A, B, C und D Wasserstoff oder eine Methylgruppe in beliebiger Kombination, m und n die Zahlen 0, 1 oder 2 bedeutet, wobei die Summe aus m und n 1 oder 2 sein muss und in welcher Ar substituiertes oder unsubstituiertes Aryl und substituiertes oder unsubstituiertes Heteroaryl in beliebiger Kombination bedeutet, und in welcher R1 verzweigtes und unverzweigtes Alkyl, vorzugsweise nieder Alkyl bedeutet, deren Herstellung und Verwendung.
PCT/AT1990/000038 1989-04-24 1990-04-24 ACETALISCH GESCHÜTZTE ENANTIOMERENREINE α-ARYLALKANCARBONSÄUREN, DEREN HERSTELLUNG UND VERWENDUNG WO1990012788A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA969/89 1989-04-24
AT96989 1989-04-24

Publications (2)

Publication Number Publication Date
WO1990012788A2 WO1990012788A2 (de) 1990-11-01
WO1990012788A3 true WO1990012788A3 (de) 1990-12-13

Family

ID=3503968

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT1990/000038 WO1990012788A2 (de) 1989-04-24 1990-04-24 ACETALISCH GESCHÜTZTE ENANTIOMERENREINE α-ARYLALKANCARBONSÄUREN, DEREN HERSTELLUNG UND VERWENDUNG

Country Status (2)

Country Link
AU (1) AU5527190A (de)
WO (1) WO1990012788A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT396686B (de) * 1992-04-13 1993-11-25 Christian Dr Noe Reagention zur razemattrennung, verfahren zu ihrer herstellung und verwendung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH291375A (de) * 1950-12-13 1953-06-15 Hommels S Haematogen Ag Verfahren zur Herstellung von a-Phenylbuttersäure-diäthylaminoäthylester.
US3349114A (en) * 1963-05-17 1967-10-24 Hommel Ag Diethylaminoethoxyethyl ester of alpha-phenylbutyric acid and salts thereof
EP0083335A1 (de) * 1981-12-18 1983-07-06 Christian Dipl.-Ing. Dr. Noe Chirale, optisch aktive Verbindungen, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen für den Schutz funktioneller -OH, -SH, -NH-Gruppen, zur Racemattrennung, zur Herstellung optisch aktiver Imidoesterhydrochloride sowie optisch aktiver Ester, zur Herstellung optisch angereicherter Alkohole und zur Herstellung optisch aktiver Verbindungen durch asymmetrische Induktion

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH291375A (de) * 1950-12-13 1953-06-15 Hommels S Haematogen Ag Verfahren zur Herstellung von a-Phenylbuttersäure-diäthylaminoäthylester.
US3349114A (en) * 1963-05-17 1967-10-24 Hommel Ag Diethylaminoethoxyethyl ester of alpha-phenylbutyric acid and salts thereof
EP0083335A1 (de) * 1981-12-18 1983-07-06 Christian Dipl.-Ing. Dr. Noe Chirale, optisch aktive Verbindungen, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen für den Schutz funktioneller -OH, -SH, -NH-Gruppen, zur Racemattrennung, zur Herstellung optisch aktiver Imidoesterhydrochloride sowie optisch aktiver Ester, zur Herstellung optisch angereicherter Alkohole und zur Herstellung optisch aktiver Verbindungen durch asymmetrische Induktion

Also Published As

Publication number Publication date
WO1990012788A2 (de) 1990-11-01
AU5527190A (en) 1990-11-16

Similar Documents

Publication Publication Date Title
CA2123052A1 (en) Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
EP0955340A3 (de) Flüssige Silikon-Ester
CA2011294A1 (en) Carbonylation catalyst system
ATE105285T1 (de) Salicylaldehyd- und salicylsaeurederivate sowie deren schwefelanaloge, verfahren zu ihrer herstellung und ihre verwendung als herbizide und bioregulatoren.
EP0952151A3 (de) Zwischenverbindungen zur Herstellung von neunen Pyridoncarbonsäurederivate oder deren Salzen
UA35592C2 (uk) Похідні оцтової кислоти
CA2135751A1 (en) 4-Mercaptoacetylamino-[2] Benzazepinone(3) Derivatives, and Use as Enkephalinase Inhibitors
CA2206754A1 (en) Benzimidazole derivatives with antihistaminic activity
CA2165971A1 (en) Methylphosphonic acid ester, process for preparing the same and its use
AU638122B2 (en) 5,5-bis(perfluoroalkylheteromethyl)-2-hydroxy-2-oxo-1,3,2 -dio xaphosphorinanes, derived acyclic phosphorus acids and salts or esters thereof
ZA9410181B (en) Arylacetic acid derivatives.
CA2038848A1 (en) Hydantoin derivatives
AU1614492A (en) New peptide compound and a process for the preparation thereof
EP0505582A4 (en) Sulfonating agent and process
CA2164642A1 (en) Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
ES8604604A1 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
CA2140289A1 (en) Detergent Compositions Inhibiting Dye Transfer
ES2191364T3 (es) Agente tixotropico basado en una resina alquidica.
WO1990012788A3 (de) ACETALISCH GESCHÜTZTE ENANTIOMERENREINE α-ARYLALKANCARBONSÄUREN, DEREN HERSTELLUNG UND VERWENDUNG
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
EP0563386A4 (en) Anticancer composition and compound
AU625627B2 (en) Triazinic compounds
FI941149A (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
EP0712393A1 (de) Substituierte 4-carbamoyl-pyrrolin-2-on- und -dihydrofuran-2-on-derivate und deren verwendung als schädlingsbekämpfungsmittel
EP1314726A4 (de) Neue ester- oder amid-derivate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA HU JP KR SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA HU JP KR SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

NENP Non-entry into the national phase in:

Ref country code: CA